Generation of Regionally Specified Neural Progenitors and Functional Neurons from Human Embryonic Stem Cells under Defined Conditions

Cell Reports

Volumn 1, Issue 6, 2012, Pages 703-714

  Kirkeby, Agnete ^a,b   Grealish, Shane ^a   Wolf, Daniel A ^a,b   Nelander, Jenny ^a,b   Wood, James ^b,c   Lundblad, Martin ^a   Lindvall, Olle ^b,c   Parmar, Malin ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEVELOPMENT; BRAIN GRAFT; CELL DIFFERENTIATION; CELL FATE; CELL SPECIFICITY; CELL STRUCTURE; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; EMBRYO; EMBRYONIC STEM CELL; FEMALE; FETUS; FOREBRAIN; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCEPHALON; MOUSE; NERVE PROJECTION; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; RAT; RHOMBENCEPHALON; SIGNAL TRANSDUCTION;

AGING; ANIMALS; BODY PATTERNING; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DOPAMINE; DOPAMINERGIC NEURONS; ELECTROPHYSIOLOGICAL PHENOMENA; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MOTOR ACTIVITY; NEURAL STEM CELLS; NEURAL TUBE; NEURONS; ORGAN SPECIFICITY; PHENOTYPE; PROTEIN KINASE INHIBITORS; RATS; TELENCEPHALON; WNT SIGNALING PATHWAY;

ANIMALIA; RATTUS;

EID: 84863094725     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2012.04.009     Document Type: Article

References (46)

1. Ahrlund-Richter L., De Luca M., Marshak D.R., Munsie M., Veiga A., Rao M. Isolation and production of cells suitable for human therapy: challenges ahead. Cell Stem Cell 2009, 4:20-26.
2. Andersson E., Tryggvason U., Deng Q., Friling S., Alekseenko Z., Robert B., Perlmann T., Ericson J. Identification of intrinsic determinants of midbrain dopamine neurons. Cell 2006, 124:393-405.
3. Aubry L., Bugi A., Lefort N., Rousseau F., Peschanski M., Perrier A.L. Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats. Proc. Natl. Acad. Sci. USA 2008, 105:16707-16712.
4. Baker M. Stem cells in culture: defining the substrate. Nat. Methods 2011, 8:293-297.
5. Bonilla S., Hall A.C., Pinto L., Attardo A., Götz M., Huttner W.B., Arenas E. Identification of midbrain floor plate radial glias-lika cells as dopaminergic progenitors. Glia 2008, 56:809-820.
6. Brederlau A., Correia A.S., Anisimov S.V., Elmi M., Paul G., Roybon L., Morizane A., Bergquist F., Riebe I., Nannmark U., et al. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 2006, 24:1433-1440.
7. Brundin P., Strecker R.E., Widner H., Clarke D.J., Nilsson O.G., Astedt B., Lindvall O., Björklund A. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Exp. Brain Res. 1988, 70:192-208.
8. Chambers S.M., Fasano C.A., Papapetrou E.P., Tomishima M., Sadelain M., Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 2009, 27:275-280.
9. Chiba S., Lee Y.M., Zhou W., Freed C.R. Noggin enhances dopamine neuron production from human embryonic stem cells and improves behavioral outcome after transplantation into Parkinsonian rats. Stem Cells 2008, 26:2810-2820.
10. Cooper O., Hargus G., Deleidi M., Blak A., Osborn T., Marlow E., Lee K., Levy A., Perez-Torres E., Yow A., Isacson O. Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid. Mol. Cell. Neurosci. 2010, 45:258-266.
11. Fasano C.A., Chambers S.M., Lee G., Tomishima M.J., Studer L. Efficient derivation of functional floor plate tissue from human embryonic stem cells. Cell Stem Cell 2010, 6:336-347.
12. Ferri A.L., Lin W., Mavromatakis Y.E., Wang J.C., Sasaki H., Whitsett J.A., Ang S.L. Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner. Development 2007, 134:2761-2769.
13. Frame S., Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem. J. 2001, 359:1-16.
14. Gaspard N., Vanderhaeghen P. From stem cells to neural networks: recent advances and perspectives for neurodevelopmental disorders. Dev. Med. Child Neurol. 2011, 53:13-17.
15. Gaspard N., Bouschet T., Hourez R., Dimidschstein J., Naeije G., van den Ameele J., Espuny-Camacho I., Herpoel A., Passante L., Schiffmann S.N., et al. An intrinsic mechanism of corticogenesis from embryonic stem cells. Nature 2008, 455:351-357.
16. Grealish S., Jönsson M.E., Li M., Kirik D., Björklund A., Thompson L.H. The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease. Brain 2010, 133:482-495.
17. Hebsgaard J.B., Nelander J., Sabelström H., Jönsson M.E., Stott S., Parmar M. Dopamine neuron precursors within the developing human mesencephalon show radial glial characteristics. Glia 2009, 57:1648-1658.
18. Heins N., Lindahl A., Karlsson U., Rehnström M., Caisander G., Emanuelsson K., Hanson C., Semb H., Björquist P., Sartipy P., Hyllner J. Clonal derivation and characterization of human embryonic stem cell lines. J. Biotechnol. 2006, 122:511-520.
19. Hoffman A.F., Lupica C.R., Gerhardt G.A. Dopamine transporter activity in the substantia nigra and striatum assessed by high-speed chronoamperometric recordings in brain slices. J. Pharmacol. Exp. Ther. 1998, 287:487-496.
20. Isacson O., Deacon T.W., Pakzaban P., Galpern W.R., Dinsmore J., Burns L.H. Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres. Nat. Med. 1995, 1:1189-1194.
21. Koch P., Kokaia Z., Lindvall O., Brüstle O. Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling. Lancet Neurol. 2009, 8:819-829.
22. Koch P., Opitz T., Steinbeck J.A., Ladewig J., Brüstle O. A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration. Proc. Natl. Acad. Sci. USA 2009, 106:3225-3230.
23. Kriks S., Shim J.W., Piao J., Ganat Y.M., Wakeman D.R., Xie Z., Carrillo-Reid L., Auyeung G., Antonacci C., Buch A., et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 2011, 480:547-551.
24. Li X.J., Zhang X., Johnson M.A., Wang Z.B., Lavaute T., Zhang S.C. Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells. Development 2009, 136:4055-4063.
25. Mendez I., Sanchez-Pernaute R., Cooper O., Viñuela A., Ferrari D., Björklund L., Dagher A., Isacson O. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain 2005, 128:1498-1510.
26. Miura K., Okada Y., Aoi T., Okada A., Takahashi K., Okita K., Nakagawa M., Koyanagi M., Tanabe K., Ohnuki M., et al. Variation in the safety of induced pluripotent stem cell lines. Nat. Biotechnol. 2009, 27:743-745.
27. Nat R., Nilbratt M., Narkilahti S., Winblad B., Hovatta O., Nordberg A. Neurogenic neuroepithelial and radial glial cells generated from six human embryonic stem cell lines in serum-free suspension and adherent cultures. Glia 2007, 55:385-399.
28. Nelander J., Hebsgaard J.B., Parmar M. Organization of the human embryonic ventral mesencephalon. Gene Expr. Patterns 2009, 9:555-561.
29. Nikkhah G., Winkler M., Rödter A., Samii M. Microtransplantation of nigral dopamine neurons: a " step by step" recipe. Neuromethods: Cell and Tissue Transplantation in the CNS 2000, Humana, Totowas, NJ. S. Dunnett, A. Boulton, G. Baker (Eds.).
30. Nordström U., Jessell T.M., Edlund T. Progressive induction of caudal neural character by graded Wnt signaling. Nat. Neurosci. 2002, 5:525-532.
31. Ono Y., Nakatani T., Sakamoto Y., Mizuhara E., Minaki Y., Kumai M., Hamaguchi A., Nishimura M., Inoue Y., Hayashi H., et al. Differences in neurogenic potential in floor plate cells along an anteriorposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells. Development 2007, 134:3213-3225.
32. Pankratz M.T., Li X.J., Lavaute T.M., Lyons E.A., Chen X., Zhang S.C. Directed neural differentiation of human embryonic stem cells via an obligated primitive anterior stage. Stem Cells 2007, 25:1511-1520.
33. Perrier A.L., Tabar V., Barberi T., Rubio M.E., Bruses J., Topf N., Harrison N.L., Studer L. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 2004, 101:12543-12548.
34. Placzek M., Briscoe J. The floor plate: multiple cells, multiple signals. Nat. Rev. Neurosci. 2005, 6:230-240.
35. Rodríguez-Gómez J.A., Lu J.Q., Velasco I., Rivera S., Zoghbi S.S., Liow J.S., Musachio J.L., Chin F.T., Toyama H., Seidel J., et al. Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease. Stem Cells 2007, 25:918-928.
36. Roy N.S., Cleren C., Singh S.K., Yang L., Beal M.F., Goldman S.A. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat. Med. 2006, 12:1259-1268.
37. Seminatore C., Polentes J., Ellman D., Kozubenko N., Itier V., Tine S., Tritschler L., Brenot M., Guidou E., Blondeau J., et al. The postischemic environment differentially impacts teratoma or tumor formation after transplantation of human embryonic stem cell-derived neural progenitors. Stroke 2010, 41:153-159.
38. Sonntag K.C., Pruszak J., Yoshizaki T., van Arensbergen J., Sanchez-Pernaute R., Isacson O. Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. Stem Cells 2007, 25:411-418.
39. Strömberg I., Almqvist P., Bygdeman M., Finger T.E., Gerhardt G., Granholm A.C., Mahalik T.J., Seiger A., Olson L., Hoffer B. Human fetal mesencephalic tissue grafted to dopamine-denervated striatum of athymic rats: light- and electron-microscopical histochemistry and in vivo chronoamperometric studies. J. Neurosci. 1989, 9:614-624.
40. Swistowski A., Peng J., Han Y., Swistowska A.M., Rao M.S., Zeng X. Xeno-free defined conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons derived from them. PLoS ONE 2009, 4:e6233.
41. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
42. Thompson L., Barraud P., Andersson E., Kirik D., Björklund A. Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections. J. Neurosci. 2005, 25:6467-6477.
43. Ulloa F., Martí E. Wnt won the war: antagonistic role of Wnt over Shh controls dorso-ventral patterning of the vertebrate neural tube. Dev. Dyn. 2010, 239:69-76.
44. Wictorin K., Brundin P., Gustavii B., Lindvall O., Björklund A. Reformation of long axon pathways in adult rat central nervous system by human forebrain neuroblasts. Nature 1990, 347:556-558.
45. Wictorin K., Brundin P., Sauer H., Lindvall O., Björklund A. Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats. J. Comp. Neurol. 1992, 323:475-494.
46. Zuddas A., Corsini G.U., Barker J.L., Kopin I.J., Di Porzio U. Specific reinnervation of lesioned mouse striatum by grafted mesencephalic dopaminergic neurons. Eur. J. Neurosci. 1991, 3:72-85.